Drawing for RXALL

USPTO serial 87086936

RXALL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SIRIGNANO, EMMA MARIE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RXALL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John J. Arnott

JOHN J. ARNOTT MUNCK WILSON MANDALA LLPP.O. DRAWER 800889DOCKET CLERKDALLAS, TX 75380

Goods and services

ClassDescriptionStatusFirst use
035Retail pharmacy services; online retail pharmacy services; retail drug store services; on-line retail drug store services; Specialized retail pharmacy services for patients with particular medical conditions; Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; patient care management services, namely, medical cost managementACTIVE—
036Providing insurance coverage information; Providing information about healthcare insurance plans and coverageACTIVE—
039Pharmacy packaging service that aligns, sorts and packages a patient's medications by date and time into individual packetsACTIVE—
044Providing patient medication histories online; medical information services, namely, providing a website whereby users may obtain an automatic check of drug-to-drug interactions, drug-allergy interactions, drug formulary and patient eligibility data; Providing a web-based on-line portal in the health care services field for pharmacists to obtain and administratively process prior authorization for prescription drugs, and for doctors to provide electronic prior authorizations of prescriptions; On-line computer services, namely, providing on-line prescription drug authorization, management and fulfilling of prescription orders to consumers, providers, insurers, and other participants in the healthcare industry; patient care management services, namely, medication therapy management; providing insurance coverage information; Providing information about healthcare insurance plans and coverage; Providing medical information regarding patients, prescription drugs and drug therapy; allergy testing servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 18, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 18, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 4, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 14, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 20, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 20, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 30, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 14, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 1, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 31, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 31, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2016ALIEASSIGNED TO LIE—
Oct 12, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 12, 2016GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Oct 12, 2016GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Oct 12, 2016EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Oct 12, 2016CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Oct 5, 2016DOCKASSIGNED TO EXAMINER—
Jul 2, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jul 1, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 1, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance